RED BANK, N.J., Oct. 28, 2021 /PRNewswire/ -- Provention Bio,
Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to
intercepting and preventing immune-mediated disease, today
announced that it will report its third quarter 2021 financial
results on Thursday, November 4,
2021, before the opening of the U.S. financial markets.
Subsequently, at 8:00 am E.T., the
company will host a conference call to discuss its financial
results and provide a corporate update.
To access the call, please dial 1-888-347-7861 (domestic) or
1-412-902-4247 (international) ten minutes prior to the start
time and ask to be connected to the "Provention Bio Call." An audio
webcast will also be available on the "Events and Webcasts" page of
the Investors section of the Company's website,
www.proventionbio.com. An archived webcast will be available on the
Company's website approximately two hours after the conference
call.
About Provention Bio, Inc.:
Provention Bio, Inc. (Nasdaq: PRVB) is a biopharmaceutical
company focused on advancing the development of investigational
therapies that may intercept and prevent debilitating and
life-threatening immune-mediated disease. The Company's pipeline
includes clinical-stage product candidates that have demonstrated
in pre-clinical or clinical studies proof-of-mechanism and/or
proof-of-concept in autoimmune diseases, including type 1 diabetes,
celiac disease and lupus. Visit www.ProventionBio.com for more
information and follow us on Twitter: @ProventionBio.
Internet Posting of Information:
Provention Bio, Inc. uses its
website, www.proventionbio.com, as a means of disclosing
material nonpublic information and for complying with its
disclosure obligations under Regulation FD. Such disclosures will
be included on the Company's website in the "News" section.
Accordingly, investors should monitor this portion of the Company's
website, in addition to following its press
releases, SEC filings and public conference calls and
webcasts.
Investor Contacts:
Robert
Doody, VP of Investor Relations
rdoody@proventionbio.com
484-639-7235
Sam Martin, Argot Partners
sam@argotpartners.com
212-600-1902
Media Contact:
Lori Rosen, LDR Communications
lori@ldrcommunications.com
917-553-6808
View original content to download
multimedia:https://www.prnewswire.com/news-releases/provention-bio-to-report-third-quarter-2021-financial-results-on-november-4-2021-301410473.html
SOURCE Provention Bio, Inc.